Compound Summary
药名: | Artemisinin |
别名: | BSPBio_002998; KBio2_001831; BRN 4194670; Prestwick1_000498; LMPR01030025; Spectrum_001351; Artemisia annua L., extract; (3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10(3H)-one; KBio2_004399; KBioSS_001831; KBio2_006967; Spectrum2_001512; Huanghuahaosu; Qinghaosu; Qing Hao Su; SPBio_001583; Artemisinine [French]; Artemisininum [Latin]; Arteannuin; (+)-Artemisinin; Artemisinina [Spanish]; artemisinin ; BPBio1_000435; Cotexin; KBio1_000656; Prestwick3_000498; KBioGR_000982; Qinghosu; Qinghaosu [Chinese]; Artesin; Quing Hau Sau; Prestwick2_000498; Spectrum5_001098; IDI1_000656; C09538; DivK1c_000656; Artemisinin [INN]; Artemisine; Qing Hau SU; 3,12-Epoxy-12H-pyranol(4,3-j)-1,2-benzodioxepin-10(3H)-one, octahydro-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12aR*)-(+)-; BSPBio_000395; Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10(3H)-one; NSC 369397; Spectrum3_001549; KBio3_002498; 63968-64-9; NINDS_000656; SPBio_002316; Spectrum4_000721; D02481; Artemisinin; Artemisinine; Prestwick0_000498; Qing Hau Sau [Chinese] |
分子式: | C15H22O5 |
Smiles: | C1([H])([H])[C@]2([H])[C@]3([C@@]([H])(O[C@@](C([H])([H])[H])(OO3)C([H])([H])C4([H])[H])OC(=O)[C@]2([H])C([H])([H])[H])[C@]4([H])[C@]([H])(C([H])([H])[H])C1([H])[H] |
成分: | HBIN016960 |
OB_score: | 49.87926 |
CAS_id: | 63968-64-9 |
SymMap_id: | SMIT08863 |
TCMID_id: | 23257 |
TCMSP_id: | MOL007424 |
PubChem_id: | 137704955 |
DrugBank_id: | DB13132 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE005093 | Massa Medicata Fermentata | 六神曲 | Treatment of retention of food manifested as epigastric and abdominal distension and fullness, no appetite, gurgling sound and diarrhea. Medicated leaven (Shenqu) is used with Hawthorn fruit (Shanzha) and Germinated barley (Maiya)./Treatment of retention of food manifested as epigastric and abdominal distension and fullness, no appetite, gurgling sound and diarrhea. Medicated leaven (Shenqu) is used with Hawthorn fruit (Shanzha) and Germinated barley (Maiya). | |||
TCMBANKHE008476/YEM-68 | Artemisia annua|Artemisia annua L. | 黄花蒿 | 黄花蒿 | 云南民族药物志:第一卷 | To clear heat, resolve summerheat, eliminate steam, interrupt malaria./Summerheat-heat, summerheat-damp, damp warmth, yin vacuity fever, malaria, jaundice. | 阿昌族/白族/傣族/德昂族/独龙族/景颇族/傈僳族/纳西族/怒族/瑶族/彝族/藏族/壮族 |
TCMBANKHE006570/YEM-68 | Herba Artemisiae Annuae|Artemisia annua L. | 青蒿|黄花蒿 | 黄花蒿 | 云南民族药物志:第一卷 | To remove summer-heat, to relieve consumptive fever,and to stop malarial attacks./See Artemisia annua. | 阿昌族/白族/傣族/德昂族/独龙族/景颇族/傈僳族/纳西族/怒族/瑶族/彝族/藏族/壮族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI004122 | Parasitemia | disease | Pathological Conditions, Signs and Symptoms; Infections | 21709259 |
TCMBANKDI005503 | Malaria, Falciparum | disease | Infections | 25910630 |
TCMBANKDI012119 | Nerve Degeneration | phenotype | Pathological Conditions, Signs and Symptoms | 27242266 |
TCMBANKDI014919 | Malaria, Vivax | disease | Infections | 30337251 |
TCMBANKDI015757 | Malaria | disease | Infections | 31806760 |
TCMBANKDI023904 | Macular degeneration | disease | Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 27372058 |
TCMBANKDI023986 | Coinfection | phenotype | Infections | 30587297 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000068 | VEGFC | Flt4-L; LMPH1D; LMPHM4; VRP | vascular endothelial growth factor C |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE000264 | ABCB1 | ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1 | ATP binding cassette subfamily B member 1 |
TCMBANKGE000453 | NR1I3 | CAR; CAR1; MB67 | nuclear receptor subfamily 1 group I member 3 |
TCMBANKGE000458 | CYP2B6 | CPB6; CYP2B; CYP2B7; CYP2B7P; CYPIIB6; EFVM; IIB1; P450 | cytochrome P450 family 2 subfamily B member 6 |
TCMBANKGE001007 | NR1I2 | BXR; ONR1; PAR; PAR1; PAR2; PARq; PRR; PXR; SAR; SXR | nuclear receptor subfamily 1 group I member 2 |
TCMBANKGE001008 | CYP3A4 | CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1 | cytochrome P450 family 3 subfamily A member 4 |
TCMBANKGE001076 | SOD2 | GClnc1; IPO-B; IPOB; MNSOD; MVCD6; Mn-SOD | superoxide dismutase 2 |
TCMBANKGE001097 | HIF1A | HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78 | hypoxia inducible factor 1 subunit alpha |
TCMBANKGE001148 | VEGFA | MVCD1; VEGF; VPF | vascular endothelial growth factor A |
TCMBANKGE001170 | CDK4 | CMM3; PSK-J3 | cyclin dependent kinase 4 |
TCMBANKGE001184 | RELA | CMCU; NFKB3; p65 | RELA proto-oncogene, NF-kB subunit |
TCMBANKGE003984 | TDP1 | - | tyrosyl-DNA phosphodiesterase 1 |
TCMBANKGE007368 | GSTP1 | DFN7; FAEES3; GST3; GSTP; HEL-S-22; PI | glutathione S-transferase pi 1 |
TCMBANKGE013273 | PRDX4 | AOE37-2; AOE372; HEL-S-97n; PRX-4 | peroxiredoxin 4 |
TCMBANKGE014249 | GSTA1 | GST-epsilon; GST2; GSTA1-1; GTH1 | glutathione S-transferase alpha 1 |